Jim Cramer’s Top 10 Stock Market Moves to Watch Today

9 min read
2 views
Jul 15, 2026

Wholesale prices dropped more than expected, banks delivered solid results, and several big names are moving on earnings. Jim Cramer breaks down the top 10 things shaping today's market action — but one tech giant's drop might signal deeper shifts ahead.

Financial market analysis from 15/07/2026. Market conditions may have changed since publication.

Walking into another trading day always brings a mix of anticipation and questions about where the momentum might take us. Markets never sleep, and sometimes the overnight developments set the tone for everything that follows. Today feels particularly interesting after a string of economic readings and corporate reports that have investors recalibrating their expectations.

Navigating Today’s Market Landscape With Fresh Data

The latest wholesale inflation figures came in softer than many anticipated, dropping 0.3 percent month-over-month when flat readings were the consensus call. This follows yesterday’s consumer price update and paints a picture of easing pressures, especially with lower gasoline prices playing a major role. For anyone watching the broader economy, these numbers provide a bit of breathing room and help explain why stock futures edged slightly higher in early action, led by strength in semiconductor-related names.

I’ve always believed that inflation trends act like the invisible hand guiding investor sentiment. When they moderate without signaling weakness, it often opens the door for more constructive positioning. Of course, one report doesn’t make a trend, but the direction here feels encouraging for those hoping for a supportive backdrop into the second half of the year.

ASML’s Strong Results and the AI Chip Boom

One name grabbing attention this morning is the Dutch chip equipment leader ASML, trading up over 3 percent after delivering a standout quarter and raising full-year guidance for the second time. Their extreme ultraviolet lithography machines remain essential for producing advanced AI chips, making them a critical player in the technology supply chain. Intel stands among their important customers, and the enthusiasm around this space reflects broader optimism in tech.

What strikes me is how consistently this company has performed over recent years. The market’s positive reaction today seems to capture the overall mood more than any single surprise. Still, when you consider the capital-intensive nature of semiconductor manufacturing and the insatiable demand for computing power, it’s hard not to see why investors remain drawn to these names. I’ll be diving deeper into related opportunities like Intel in upcoming discussions.

It’s been fabulous for years now. You can’t make AI chips without their machines.

That kind of positioning in a high-growth area like artificial intelligence tends to reward patient shareholders. Of course, valuations matter, and any pullback could create interesting entry points for those building longer-term positions.

Bank Earnings Season Highlights Investment Banking Strength

Morgan Stanley reported a solid top and bottom line beat, though the numbers didn’t quite match the fireworks we saw from Goldman Sachs the day before. Both firms underscore just how favorable the current environment has become for investment banks. IPO activity, mergers and acquisitions, plus healthy debt and equity issuance have combined to create a strong tailwind.

After climbing in sympathy with its rival yesterday, Morgan Stanley shares opened slightly lower this morning. These reactions often reflect high expectations already baked into prices. In my experience, when the backdrop supports multiple revenue streams like advisory fees and trading, the sector tends to deliver consistent performance over time.

  • Goldman Sachs stood out with exceptional demand across businesses
  • JPMorgan delivered balanced strength
  • Bank of America showed resilience
  • Citigroup posted steady results
  • Wells Fargo held its ground sufficiently for continued portfolio inclusion

This ranking reflects not just headline numbers but the quality of execution in a complex operating environment. Goldman in particular closed at record levels recently, facing what some might call a high-quality problem of managing excess demand. Analyst upgrades, such as Barclays lifting its price target significantly while maintaining a buy rating, add further validation.

BlackRock’s Massive Asset Growth and Market Confidence

Asset manager BlackRock posted impressive second-quarter results, attracting $192 billion in net flows and pushing assets under management to a staggering $15.3 trillion. Revenue climbed 31 percent with operating margins reaching multi-year highs. While private credit exposure had created some concerns earlier in the year, these figures demonstrate the company’s enduring appeal to investors worldwide.

Shares jumped around 5 percent in premarket trading, rewarding those who had faith in the firm’s diversified platform. In today’s world of index funds, ETFs, and active strategies, scale combined with innovation creates a powerful competitive advantage. I’ve long admired how BlackRock navigates market cycles while continuing to grow its footprint.


Healthcare Giants Deliver Mixed but Actionable Results

Johnson & Johnson came through with a beat-and-raise quarter, highlighted by strong performance from key growth driver Tremfya. Despite some softness in the medical device segment, particularly cardiology, the overall report reinforces confidence in the company’s pipeline. The stock traded lower by about 2 percent initially, which sometimes creates opportunities once initial reactions settle.

Healthcare investing requires patience because product cycles and regulatory factors can introduce volatility. Yet names with diversified portfolios and innovative therapies often reward holders over the long haul. J&J’s ability to address device-side challenges will be worth monitoring closely in coming quarters.

The Obesity Treatment Race Heats Up

Recent reports suggest Novo Nordisk’s Wegovy may hold an edge over Eli Lilly’s offering in terms of weight-loss effectiveness based on separate studies. Patient tolerance for certain lifestyle adjustments also appears higher with one option. That said, it’s still early days for the newer entrant, and marketing efforts could shift the narrative as awareness grows.

The broader weight management category represents one of the more dynamic areas in pharmaceuticals right now. Competition typically benefits patients through innovation and potentially better pricing over time. For investors, distinguishing between short-term headlines and sustainable market share will be crucial.

It’s still early, and marketing efforts are just getting going.

Aerospace and Defense Opportunities Amid Valuation Adjustments

Morgan Stanley trimmed its price target on Honeywell’s aerospace business, citing recent volatility and the need for greater selectivity. Fundamentals in aerospace and defense remain constructive heading into earnings season. This segment, shaped significantly during the tenure of former leadership, continues to offer exposure to long-term secular trends.

Any weakness created by target adjustments could represent a chance to add to positions for those bullish on the industry’s outlook. Defense spending patterns and commercial aviation recovery provide multiple levers for growth. In my view, selective buying during dips has historically served portfolios well in this space.

IBM Faces Challenges in Shifting Tech Spending Priorities

IBM received a downgrade to hold from buy at Oppenheimer following a series of estimate misses in its preliminary release. The stock experienced a sharp decline, marking one of its worst single-day performances. The company appears caught on the less favored side of corporate technology budgets moving toward AI hardware and memory solutions.

Timing recoveries in such situations requires careful analysis. While IBM maintains strong franchises in various areas, the pace of adaptation to new spending priorities will determine when sentiment might improve. For now, caution seems prudent until clearer signs of stabilization emerge.

Potential Fintech Consolidation With PayPal in Play

Reports indicate payments specialist Stripe and private equity firm Advent International submitted a joint bid for PayPal at $60.50 per share, potentially valuing the company above $53 billion. Such a transaction could mark the beginning of meaningful consolidation in fintech, an industry that has seen numerous players struggle to maintain momentum.

PayPal has traded well below its peak from several years ago, reflecting challenges in sustaining growth amid increased competition. A deal at this level might provide a floor while highlighting the value of established platforms. Consolidation often creates stronger entities better positioned to innovate and compete globally.

Beyond the immediate headlines, today’s developments remind us how interconnected various market segments have become. From inflation readings influencing rate expectations to individual company results reshaping sector rotations, each piece contributes to the larger puzzle.

Broader Implications for Portfolio Construction

Putting it all together, the softer inflation print supports a narrative of controlled economic cooling without tipping into recession territory. This environment historically favors equities, particularly those with pricing power and growth characteristics. Technology and financials have led recent moves, but opportunities likely exist across other sectors for diversified investors.

  1. Monitor upcoming economic data for confirmation of disinflation trends
  2. Evaluate bank sector exposure given strong capital markets activity
  3. Assess technology leaders with direct AI exposure versus those lagging
  4. Look for healthcare names where temporary weakness creates entry points
  5. Consider selective additions in industrials and aerospace on pullbacks

Risk management remains essential even in constructive setups. Position sizing, regular rebalancing, and staying informed about both macroeconomic and company-specific factors help navigate inevitable volatility. No single day or report defines the market’s direction, but patterns do emerge when you step back.

One aspect I find particularly noteworthy is how quickly sentiment can shift based on earnings quality rather than just quantity. Companies that exceed expectations while providing positive forward commentary tend to sustain momentum better than those merely hitting numbers. This discernment separates strong performers from the pack over time.

Semiconductor Strength and Future Catalysts

The early leadership in semiconductor stocks aligns with continued excitement around artificial intelligence applications. Demand for advanced computing capabilities shows few signs of slowing, supporting investment across the supply chain. While valuations in some areas appear elevated, innovation cycles often justify premiums for market leaders.

Investors might consider how different segments within tech interact. Hardware enablers, software platforms, and end-user applications each play distinct roles. Understanding these relationships can improve decision-making when allocating capital.


Financial stocks benefiting from higher activity levels illustrate another key theme: operational leverage in improving environments. When transaction volumes rise across advisory, underwriting, and trading, profitability can expand meaningfully. This dynamic has played out favorably for several major institutions recently.

Asset managers like BlackRock benefit from both market appreciation and inflows, creating a virtuous cycle. Their results highlight the power of scale in wealth management. For retail investors, this might encourage considering exposure to professional money management platforms indirectly through ownership of the firms themselves.

Healthcare Innovation and Long-Term Trends

The competition in weight management therapies reflects larger societal shifts toward preventive health and wellness. Companies investing heavily in research and development position themselves at the forefront of these trends. Success depends not only on clinical outcomes but also on accessibility, pricing, and patient adherence.

Beyond obesity treatments, broader pharmaceutical pipelines contain numerous catalysts. Patent expirations, new approvals, and geographic expansion all influence company trajectories. Diversification within healthcare helps mitigate risks associated with individual product outcomes.

Industrial and Defense Sector Resilience

Aerospace and defense spending benefits from both commercial recovery and geopolitical considerations. Companies with strong backlogs and technological differentiation tend to fare better through economic cycles. Valuation resets sometimes provide attractive risk-reward setups for long-term oriented investors.

Analyzing these businesses requires looking past quarterly fluctuations to multi-year contracts and replacement cycles. Patience often proves valuable when fundamentals remain intact despite temporary market skepticism.

Technology Adaptation and Corporate Spending Shifts

The challenges faced by certain legacy technology providers highlight the importance of staying relevant in rapidly evolving markets. Corporate budgets increasingly prioritize AI infrastructure and related capabilities. Firms that successfully pivot can recapture momentum, while others may face prolonged pressure.

This transition period creates both risks and opportunities. Identifying which companies are best positioned requires examining their product roadmaps, customer feedback, and competitive positioning. Such analysis takes time but often yields better investment outcomes.

Fintech Evolution and M&A Potential

The reported interest in PayPal underscores how maturation in fintech might lead to increased deal activity. Many companies raised capital during favorable periods but now face pressure to demonstrate sustainable profitability. Strategic buyers or private equity could see value in established user bases and infrastructure.

Consolidation waves typically reshape industries, creating larger players with enhanced capabilities. Investors should watch for similar themes across other segments where scale advantages become more pronounced.

Looking ahead, several factors will influence market direction. Interest rate trajectories, corporate earnings quality, geopolitical developments, and technological breakthroughs all play important roles. Maintaining flexibility while adhering to core investment principles helps weather different environments.

One lesson I’ve internalized over years of market observation is the value of balanced perspectives. Optimism grounded in data tends to serve better than either unchecked enthusiasm or perpetual caution. Today’s reports offer reasons for measured positivity while reminding us that selectivity remains key.

Whether you’re reviewing your portfolio allocations, considering new positions, or simply staying informed, focusing on fundamentals over noise generally leads to better decisions. The interplay between macroeconomic indicators and individual company stories creates the rich tapestry that makes investing both challenging and rewarding.

As we move through this earnings season, pay attention not just to the numbers but to the guidance and tone from management teams. Those insights often provide the clearest signals about future performance. In a complex market, knowledge combined with discipline forms the foundation for long-term success.

The coming days and weeks will bring more data points and corporate updates. Each contributes to our understanding of the current cycle. By staying engaged without overreacting to daily fluctuations, investors can position themselves thoughtfully for whatever lies ahead.

Remember that markets reward those who do their homework and maintain perspective. Today’s developments, from inflation moderation to sector-specific earnings, offer plenty of food for thought. The key is synthesizing this information into coherent strategies aligned with individual goals and risk tolerance.

In wrapping up these morning observations, the overall tone feels constructive despite some mixed individual reactions. Strength in certain technology and financial names, alongside potential opportunities in healthcare and industrials, suggests a market with multiple avenues for participation. As always, thorough analysis and prudent risk management should guide your approach.

Blockchain technology is bringing us the internet of value: a new platform to reshape the world of business and transform the old order of human affairs for the better.
— Don Tapscott
Author

Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.

Related Articles

?>